Gene · 9180
Papers1,423
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,423
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Lipid Metabolic Dysregulation Driven by OSMR Mutations Underlies Amyloidogenesis in Primary Localized Cutaneous Amyloidosis. | Adv Sci (Weinh) | 2026 | 42811488 | PubTator, text mining | PubMed |
| The Role of the OSM/OSMRβ Axis in Chronic Liver Disease Progression and Hepatocellular Carcinoma Development: A Focus on MASLD/MASH. | Int J Mol Sci | 2026 | 42794644 | PubTator, text mining | PubMed |
| Oncostatin M as a Multifunctional Regulator of Breast Cancer Progression: Current Insights and Future Therapeutic Avenues. | IUBMB Life | 2026 | 42746957 | PubTator, text mining | PubMed |
| : Interleukin-31 in Atopic Dermatitis and Prurigo Nodularis: Pathophysiology, Neuroimmune Mechanisms, and Clinical Efficacy of Nemolizumab. | J Drugs Dermatol | 2026 | 42696343 | PubTator, text mining | PubMed |
| Identification of Glioblastoma Cell Surface Proteins and Assessment of Their Expression Across Patient-Derived Stem-Like Cell Cultures. | J Proteome Res | 2026 | 42695909 | PubTator, text mining | PubMed |
| Tape Strip Transcriptomics Reveal Nemolizumab Effects on Pruritus, Hyperplasia, Inflammation, and Extracellular Matrix Markers in Patients With Moderate-to-Severe Atopic Dermatitis. | Allergy | 2026 | 42693785 | PubTator, text mining | PubMed |
| Autosomal recessive OSMRβ deficiency: Connecting OSM and/or IL-31 with atopy. | J Hum Immun | 2026 | 42639505 | PubTator, text mining | PubMed |
| Cryo-EM structure of the interleukin-31 receptor complex defines non-canonical interactions that confer receptor specificity. | J Biol Chem | 2026 | 42637078 | PubTator, text mining | PubMed |
| KLF4 in Smooth Muscle Cell-Derived Progenitor Cells Is Essential for Angiotensin II-Induced Cardiac Inflammation and Fibrosis. | Arterioscler Thromb Vasc Biol | 2026 | 42619593 | PubTator, text mining | PubMed |
| Longitudinal transcriptomic analysis of mucosa in ulcerative colitis after anti-tumor necrosis factor withdrawal compared to continued treatment. | J Crohns Colitis | 2026 | 42586604 | PubTator, text mining | PubMed |
| Activation of OSMR-STAT3 signaling by AID promotes immune microenvironment remodeling in hepatocellular carcinoma. | Biochim Biophys Acta Mol Basis Dis | 2026 | 42462445 | PubTator, text mining | PubMed |
| Induction of human pruriceptors from pluripotent stem cells via transcription factors. | Stem Cell Reports | 2026 | 42425092 | PubTator, text mining | PubMed |
| Human germline biallelic loss-of-function OSMR variants cause severe allergic disease. | J Hum Immun | 2026 | 42221229 | PubTator, text mining | PubMed |
| Convergent Oncostatin M and IL-31 Signaling in Chronic Pruritic Dermatoses: A Neuroimmune Janus Kinase-Signal Transducer and Activator of Transcription (JAK-STAT) Perspective. | Cureus | 2026 | 42220857 | PubTator, text mining | PubMed |
| Population genomics and disease risk of primary cutaneous amyloidosis: A prominent genodermatosis of Southeast Asia. | J Formos Med Assoc | 2026 | 42215407 | PubTator, text mining | PubMed |
| Immunotherapy drug target identification using machine learning and patient-derived tumour explant validation. | Nat Mach Intell | 2026 | 42206145 | PubTator, text mining | PubMed |
| Antioxidant Therapy Reverses Hepatotoxicity Induced by Microcystin-LR in a Cellular Model of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). | J Xenobiot | 2026 | 42201071 | PubTator, text mining | PubMed |
| An oncostatin M receptor and chloride intracellular channel 1 crosstalk drives key oncogenic pathways in glioblastoma. | Signal Transduct Target Ther | 2026 | 42177207 | PubTator, text mining | PubMed |
| Mechanistic Insights Into OSM and IL-31 in Primary Localized Cutaneous Amyloidosis: A Narrative Review. | Int J Dermatol | 2026 | 42029085 | PubTator, text mining | PubMed |
| The mask slipped: wakeable nociceptors express OSMR/SST. | Pflugers Arch | 2026 | 42010176 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9180/papers